Free Trial

Perrigo (PRGO) Stock Price, News & Analysis

Perrigo logo
$21.98 -0.54 (-2.38%)
As of 03:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Perrigo Stock (NYSE:PRGO)

Advanced

Key Stats

Today's Range
$21.96
$22.48
50-Day Range
$20.79
$28.12
52-Week Range
$20.51
$30.93
Volume
897,397 shs
Average Volume
1.53 million shs
Market Capitalization
$3.02 billion
P/E Ratio
N/A
Dividend Yield
5.28%
Price Target
$34.00
Consensus Rating
Hold

Company Overview

Perrigo Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
99th Percentile Overall Score

PRGO MarketRank™: 

Perrigo scored higher than 99% of companies evaluated by MarketBeat, and ranked 16th out of 937 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Perrigo has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 2 buy ratings, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    Perrigo has a consensus price target of $34.00, representing about 54.6% upside from its current price of $21.99.

  • Amount of Analyst Coverage

    Perrigo has only been the subject of 3 research reports in the past 90 days.

  • Read more about Perrigo's stock forecast and price target.
  • Earnings Growth

    Earnings for Perrigo are expected to grow by 19.53% in the coming year, from $2.56 to $3.06 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Perrigo is -37.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Perrigo is -37.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Perrigo has a P/B Ratio of 0.69. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Perrigo's valuation and earnings.
  • Percentage of Shares Shorted

    5.17% of the outstanding shares of Perrigo have been sold short.
  • Short Interest Ratio / Days to Cover

    Perrigo has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in Perrigo has recently decreased by 3.92%, indicating that investor sentiment is improving.
  • Dividend Leadership

    Perrigo is a leading dividend payer. It pays a dividend yield of 5.15%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Perrigo has been increasing its dividend for 23 years.

  • Dividend Sustainability

    Based on earnings estimates, Perrigo will have a dividend payout ratio of 37.91% next year. This indicates that Perrigo will be able to sustain or increase its dividend.

  • Read more about Perrigo's dividend.
  • Percentage of Shares Shorted

    5.17% of the outstanding shares of Perrigo have been sold short.
  • Short Interest Ratio / Days to Cover

    Perrigo has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in Perrigo has recently decreased by 3.92%, indicating that investor sentiment is improving.
  • News Sentiment

    Perrigo has a news sentiment score of 1.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Perrigo this week, compared to 7 articles on an average week.
  • Search Interest

    17 people have searched for PRGO on MarketBeat in the last 30 days. This is an increase of 750% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Perrigo insiders have bought more of their company's stock than they have sold. Specifically, they have bought $232,699.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 0.40% of the stock of Perrigo is held by insiders.

  • Percentage Held by Institutions

    95.91% of the stock of Perrigo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Perrigo's insider trading history.
Receive PRGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Perrigo and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PRGO Stock News Headlines

Perrigo (NYSE:PRGO) EVP Abigail Lennox Acquires 1,255 Shares
Brokerages Set Perrigo Company plc (NYSE:PRGO) Price Target at $34.00
The Dollar’s Crashing—What Are You Doing About It?
The U.S. dollar is down 10.8%—its steepest drop since 1973. As global confidence in the dollar fades, central banks are buying gold at record levels. Now, a free 2025 Gold IRA Guide shows how you can help protect your savings before the cycle worsens.tc pixel
13 Most Oversold Healthcare Stocks So Far in 2025
Analyst Report: Perrigo Company PLC
Aristotle Small/Mid Cap Equity WM Q2 2025 Commentary
See More Headlines

PRGO Stock Analysis - Frequently Asked Questions

Perrigo's stock was trading at $25.71 at the beginning of the year. Since then, PRGO stock has decreased by 14.5% and is now trading at $21.9870.

Perrigo Company plc (NYSE:PRGO) posted its earnings results on Wednesday, August, 6th. The company reported $0.57 EPS for the quarter, missing analysts' consensus estimates of $0.59 by $0.02. The firm's revenue was down .9% compared to the same quarter last year.
Read the conference call transcript
.

Perrigo subsidiaries include these companies: HRA Pharma, Ranir, Laboratoire de la Mer SAS, Geiss Destin & Dunn, ScarAway, Omega Pharma, Elan Corporation, and more.

Top institutional investors of Perrigo include GAMMA Investing LLC. Insiders that own company stock include Svend Andersen, Eduardo Guarita Bezerra, Robert Willis, Ronald Craig Janish, Geoffrey M Parker, James E Dillard III, Patrick Lockwood-Taylor, Alison Ives, Grainne Quinn, Katherine C Doyle, Jeffrey B Kindler, Thomas Farrington, Murray S Kessler and Abigail Lennox.
View institutional ownership trends
.

Shares of PRGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Perrigo investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), ServiceNow (NOW) and Arista Networks (ANET).

Company Calendar

Last Earnings
8/06/2025
Record date for 9/16 Dividend
8/29/2025
Ex-Dividend for 9/16 Dividend
8/29/2025
Dividend Payable
9/16/2025
Today
10/06/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceuticals
Current Symbol
NYSE:PRGO
CIK
1585364
Employees
8,379
Year Founded
1887

Price Target and Rating

High Price Target
$40.00
Low Price Target
$27.00
Potential Upside/Downside
+53.7%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.58)
Trailing P/E Ratio
N/A
Forward P/E Ratio
8.64
P/E Growth
N/A
Net Income
-$171.80 million
Net Margins
-1.86%
Pretax Margin
2.39%
Return on Equity
9.09%
Return on Assets
3.96%

Debt

Debt-to-Equity Ratio
0.81
Current Ratio
2.32
Quick Ratio
1.24

Sales & Book Value

Annual Sales
$4.37 billion
Price / Sales
0.70
Cash Flow
$4.96 per share
Price / Cash Flow
4.46
Book Value
$31.66 per share
Price / Book
0.70

Miscellaneous

Outstanding Shares
137,580,000
Free Float
137,033,000
Market Cap
$3.04 billion
Optionable
Optionable
Beta
0.43

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NYSE:PRGO) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners